首页> 外国专利> SUPERNATANT FROM A COCULTURE OF MACROPHAGES AND IRRADIATED LEUKOCYTES, FOR CONTROLLING TUMOUR PROGRESSION OR RESTORING ANTI-TUMOR IMMUNITY

SUPERNATANT FROM A COCULTURE OF MACROPHAGES AND IRRADIATED LEUKOCYTES, FOR CONTROLLING TUMOUR PROGRESSION OR RESTORING ANTI-TUMOR IMMUNITY

机译:来自巨噬细胞的共培养和辐照白细胞的上清液,用于控制肿瘤进展或恢复抗肿瘤免疫力

摘要

The invention relates to a method for the resolution of pro-tumour inflammation by means of a pharmaceutical preparation. Leukocytes are isolated from the buffy coat obtained from whole blood and a portion of the leukocytes is placed in a first pouch receiving a differentiation factor and stored in conditions that preserve cellular viability for several days, before a defined, fresh culture medium is supplied, after which said leukocyte portion is left to rest for a further several days, which results in the production of macrophages. A further portion of the leukocytes is placed in a second pouch and irradiated therein. The two pouches are then mixed and the supernatant is recovered to serve as pharmaceutical preparation. The invention also relates to the use in the treatment of cancers, either alone or in combination with other therapies, in human and veterinary medicine.
机译:本发明涉及通过药物制剂分辨出促肿瘤炎症的方法。从全血中获得的巴氏涂层中分离白细胞,一部分白细胞被置于接受分化因子的第一袋中并在保留细胞活力的条件下,在提供定义的新鲜培养基之前,以后其中所述白细胞部分剩下另外几天,这导致巨噬细胞的产生。将一部分白细胞置于第二袋中并在其中照射。然后将两个袋混合,回收上清液以用作药物制剂。本发明还涉及在人和兽医中单独或与其他疗法组合的癌症治疗。

著录项

  • 公开/公告号EP3810157A1

    专利类型

  • 公开/公告日2021-04-28

    原文格式PDF

  • 申请/专利权人 MED INN PHARMA;

    申请/专利号EP20190734724

  • 申请日2019-06-20

  • 分类号A61K35/15;C12N5;A61P35;A61K41;

  • 国家 EP

  • 入库时间 2022-08-24 18:24:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号